|
|
|
|
|
|
[µ¿Á¤]°í±¤°ï ±³¼ö, ½ÉÀåÇÐȸ AZÇмú»ó ¼ö»ó |
|
|
|
°í±¤°ï °¡Ãµ´ë ±æº´¿ø ½ÉÀå³»°ú ±³¼ö°¡ ÃÖ±Ù ¿¸° ´ëÇѽÉÀåÇÐȸ 58Â÷ ¿¬·ÊÇмú´ëȸ¿¡¼ '2014 ¾Æ½ºÆ®¶óÁ¦³×Ä« Çмú»ó'À» ¼ö»óÇß´Ù.
À̹ø Çмú»ó ¼ö»ó³í¹®Àº '°íÄÝ·¹½ºÅ×·ÑÇ÷Áõ ȯÀÚ¿¡¼ pravastatin°ú valsartan º´ÇÕ¿ä¹ýÀÇ ºÎ°¡ÀûÀÎ À̷οî È¿°ú'¶ó´Â Á¦¸ñÀÇ ³í¹®ÀÌ´Ù.
ÀÌ ³í¹®Àº ¹Ì±¹´ç´¢ÇÐȸ(American Diabetes Association․ADA)°¡ ¹ß°£ÇÏ´Â ¼¼°èÀû ±ÇÀ§ÀÇ ´ç´¢, ³»ºÐºñ ºÐ¾ß ÇÐȸÁö 'Diabetes Journal(SCI Impact factor 8.474)'¿¡ 2013³â 10¿ù ¹ßÇ¥ÇÑ ¹Ù ÀÖ´Ù.
|
|
|
|
|
|
|
|
|
|
|